Drug intelligence / Profile preview

MGD3

Development stage
Unknown
Lead developer
Pharmed
Modality
Small Molecules
Administration
Oral
01

Overview

MGD3 is an oral nutritional supplement developed by Pharmed. It is formulated as a combination of highly bioavailable magnesium glycine complex (magnesium glycinate) and vitamin D3 (cholecalciferol). Magnesium acts as an essential cofactor in the enzymatic activation of vitamin D3, while vitamin D3 enhances calcium absorption and bone mineralization. Together, they work synergistically to support bone, muscle, metabolic, and neurological health. MGD3 is primarily used to treat or prevent magnesium and vitamin D3 deficiencies, alleviate muscle cramps, and support musculoskeletal and metabolic disorders.

Brand names
MGD3MGD-3MGD 3MGD3 60KMGD-3 60KMGD 3 60K
Other names
magnesium glycinate + cholecalciferolmagnesium glycine complex + cholecalciferolmagnesium glycine complex + vitamin D3
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on MGD3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MGD3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call